Ozempic has a wholesale list price of $1,027.51 per pen, regardless of dose. That works out to roughly $1,000 a month before insurance, discounts, or coupons. What you actually pay, though, depends heavily on your insurance, your pharmacy, and whether you qualify for savings programs.
List Price vs. What You Actually Pay
Novo Nordisk sets the same wholesale acquisition cost for every Ozempic pen: $1,027.51, whether you’re on the 0.25 mg, 0.5 mg, 1 mg, or 2 mg dose. This is the price pharmacies pay before any rebates or negotiations, and it’s the starting point for what gets passed along to you.
Without insurance, most pharmacies charge somewhere around $915 per pen at the register. Using discount tools like Optum Perks coupons can bring that down noticeably. Costco, Walgreens, and CVS all come in around $720 per pen with a coupon applied. Walmart runs higher at roughly $989. If your doctor prescribes four pens (a common quantity for higher doses or longer fills), expect the starting price to be around $2,900.
With Commercial Insurance
If you have private insurance that covers Ozempic, the manufacturer’s savings card can drop your copay to as little as $25 for up to a three-month supply at any dose. The card covers up to $100 per month in savings and stays active for up to 48 months. That’s a significant discount, but it comes with rules: you need commercial insurance that already includes Ozempic on its formulary. People on any government insurance plan, including Medicare, Medicaid, and TRICARE, are excluded.
One exception worth noting: Federal Employees Health Benefits (FEHB) plans, Affordable Care Act marketplace plans, and state employee plans are not considered government programs for the purpose of this savings offer. If you’re on one of those, you can still use the card.
Medicare Coverage
Medicare’s relationship with Ozempic is changing. A new program called the Medicare GLP-1 Bridge sets a flat $50 copay for eligible beneficiaries, regardless of where they fall in the Part D benefit phases. Low-income subsidies don’t reduce this copay further.
To qualify, your doctor must submit a prior authorization request confirming you meet specific clinical criteria. The requirements vary by BMI. Patients with a BMI of 35 or higher qualify if the drug is prescribed alongside lifestyle changes like structured nutrition and physical activity. At a BMI of 30 or higher, you also need a qualifying condition such as heart failure, uncontrolled high blood pressure, or stage 3a or higher chronic kidney disease. At a BMI of 27 or higher, qualifying conditions include pre-diabetes, a prior heart attack, a prior stroke, or symptomatic peripheral artery disease.
Looking further ahead, Ozempic is one of the drugs selected for Medicare price negotiation under the Inflation Reduction Act. A negotiated “maximum fair price” is set to take effect on January 1, 2027, which could significantly lower what Medicare pays and what beneficiaries owe.
Patient Assistance for Uninsured Patients
Novo Nordisk runs a Patient Assistance Program for people who can’t afford the medication and don’t have coverage. To qualify, you need to be a U.S. citizen or legal resident with a total household income at or below 400% of the federal poverty level. You also can’t have private prescription coverage like an HMO or PPO plan, and you generally can’t qualify for other government programs. There are exceptions for Medicare patients who meet the other criteria and for people who applied for Medicaid but were denied.
If you qualify, the program provides the medication at no cost. The application goes through your prescribing provider.
Compounded Semaglutide
Some patients turn to compounded versions of semaglutide, the active ingredient in Ozempic. These are mixed by compounding pharmacies rather than manufactured by Novo Nordisk, and they typically cost between $129 and $497 per month depending on the provider and dose. That’s a fraction of the brand-name price, which is why they’ve become popular, especially through telehealth platforms.
The trade-off is that compounded semaglutide is not FDA-approved. It hasn’t gone through the same manufacturing oversight or testing for consistency that brand-name Ozempic has. The FDA has issued warnings about quality concerns with some compounded products. If you’re considering this route, the cost savings are real, but so are the risks of variable potency and purity.
Why It Costs So Much More in the U.S.
The price gap between the U.S. and other countries is stark. A one-month supply of Ozempic 1 mg costs about $147 in Canada and roughly $93 in the United Kingdom. That makes the U.S. list price roughly seven to eleven times higher than what patients in peer nations pay for the identical drug at the identical dose. These international prices reflect government-negotiated rates that the U.S. market historically hasn’t had, though the Medicare negotiation program is a first step in that direction.